Business Context and Reporting Period
This Form 6-K filing by CollPlant Biotechnologies Ltd. is dated June 8, 2023. The report serves to notify shareholders of an upcoming Annual and Extraordinary General Meeting scheduled for July 18, 2023, in Tel-Aviv, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing.
Guidance, Outlook, and Management Commentary
The Company announced the convening of a General Meeting to vote on proposals detailed in the attached Notice and Proxy Statement (Exhibit 99.1). The filing includes a Proxy Card (Exhibit 99.2) to allow shareholders to vote without attending in person. No specific business outlook, risk factors, or unusual items are discussed in the body of this report.
Key Facts for Investor Verification
- Verify the specific proposals to be voted upon in the attached Notice and Proxy Statement (Exhibit 99.1).
- Confirm the meeting date (July 18, 2023) and location (One Azrieli Center, Tel-Aviv) for attendance or proxy submission.
- Note that this filing does not contain updated financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial data.